Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R S Rittmaster

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1990
Effects of finasteride (MK-906), a 5 alpha-reductase inhibitor, on circulating androgens in male volunteersG J Gormley, E Stoner, R S Rittmaster, et al.
The Journal of Clinical Endocrinology and Metabolism|January 1, 1991
A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndromeJ E Nestler, L P Powers, D W Matt, et al.
The Journal of Urology|June 19, 2007
Fetal distribution of 5alpha-reductase 1 and 5alpha-reductase 2, and their input on human prostate developmentA Lunacek, C Schwentner, J Oswald, et al.
The Journal of Urology|November 24, 1999
The utility of tissue transglutaminase as a marker of apoptosis during treatment and progression of prostate cancerR S Rittmaster, L N Thomas, A S Wright, et al.
The Journal of Clinical Endocrinology and Metabolism|March 20, 1998
Effect of methimazole, with or without L-thyroxine, on remission rates in Graves' diseaseR S Rittmaster, E C Abbott, R Douglas, et al.
The Journal of Urology|October 9, 2003
5alpha-reductase type 1 immunostaining is enhanced in some prostate cancers compared with benign prostatic hyperplasia epitheliumL N Thomas, R C Douglas, J P Vessey, et al.
The Journal of Clinical Endocrinology and Metabolism|September 1, 1996
Effect of methimazole with or without exogenous L-thyroxine on serum concentrations of thyrotropin (TSH) receptor antibodies in patients with Graves' diseaseR S Rittmaster, H Zwicker, E C Abbott, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1990
Effects of finasteride (MK-906), a 5 alpha-reductase inhibitor, on circulating androgens in male volunteersG J Gormley, E Stoner, R S Rittmaster, et al.
The Journal of Clinical Endocrinology and Metabolism|January 1, 1991
A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndromeJ E Nestler, L P Powers, D W Matt, et al.
The Journal of Urology|June 19, 2007
Fetal distribution of 5alpha-reductase 1 and 5alpha-reductase 2, and their input on human prostate developmentA Lunacek, C Schwentner, J Oswald, et al.
The Journal of Urology|November 24, 1999
The utility of tissue transglutaminase as a marker of apoptosis during treatment and progression of prostate cancerR S Rittmaster, L N Thomas, A S Wright, et al.
The Journal of Clinical Endocrinology and Metabolism|March 20, 1998
Effect of methimazole, with or without L-thyroxine, on remission rates in Graves' diseaseR S Rittmaster, E C Abbott, R Douglas, et al.
The Journal of Urology|October 9, 2003
5alpha-reductase type 1 immunostaining is enhanced in some prostate cancers compared with benign prostatic hyperplasia epitheliumL N Thomas, R C Douglas, J P Vessey, et al.
The Journal of Clinical Endocrinology and Metabolism|September 1, 1996
Effect of methimazole with or without exogenous L-thyroxine on serum concentrations of thyrotropin (TSH) receptor antibodies in patients with Graves' diseaseR S Rittmaster, H Zwicker, E C Abbott, et al.
Pageof 7